Awarding a European prize is equivalent to a validation of the Technology readiness level (TRL) of the project by an independent body (EASME).
2017 H2020 SME INSTRUMENT phase-2 Topic :SMEInst-03-2017. European commission
2015 H2020 SME INSTRUMENT phase-1 Topic : BIOTEC-5a2015. European commission
2015 17th i-Lab “Créadev” BPI France
2013 15th “émergence” OSEO/BPI
2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.
REGULAXIS, a leader in peptide research and development, will presents its most recent preclinical data of REG-O3, an innovative chimeric peptide for the treatment of osteoarthritis of knee at the 2018 Osteoarthritis Research Society International World Congress (OARSI), to be held April 26-29, 2018 in Liverpool, UK.
Awarding a European prize is equivalent to a validation of the Technology readiness level (TRL) of the project by an independent body (EASME).
2017 H2020 SME INSTRUMENT phase-2 Topic :SMEInst-03-2017. European commission
2015 H2020 SME INSTRUMENT phase-1 Topic : BIOTEC-5a2015. European commission
2015 17th i-Lab “Créadev” BPI France
2013 15th “émergence” OSEO/BPI
2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.
Leave A Comment